Dimension and definition [18] | Quantitative outcomes | Qualitative outcomes | Level of analysis |
---|---|---|---|
Reach = The absolute number, proportion, and representativeness of individuals who are willing to participate in a given initiative | • Reach rate: percentage of eligible patients who agree to participate (Inclusion/number of proposals*100)a | Hospital | |
• Reasons for proposal | Hospital | ||
• Reasons for refusal | Hospital | ||
• Number of drop-outs | Pharmacies | ||
• Characteristics of the HIV populationb | Hospital | ||
• Barriers and facilitators to including patients | HCPs and patients | ||
• Patients’ selection criteria | HCPs | ||
Adoption = The absolute number, proportion, and representativeness of settings and intervention agents who are willing to initiate a program | • Adoption rate: pharmacists involved in the program among pharmacies of the Neuchâtel area (as a %age) | Pharmacies | |
• Number of involved physicians/nurses in the hospital | Hospital | ||
• Perceived motivation for and utility of the program | HCPs | ||
Implementation = implementation refers to the intervention agents’ fidelity to the various elements of an intervention’s protocolc | • Fidelity: number of delivered interviews, interval (in days) in between interviews | Pharmacies | |
• Length of time for patient follow-up (in months) | Pharmacies | ||
• Time and cost needed to deliver the intervention | Pharmacies | ||
• Fidelity and adaptationsd (use of electronic monitors, motivational interviewing, and reporting) | HCPs and patients | ||
• Implementation barriers and facilitators | HCPs and patients | ||
• Interprofessional collaboration development | HCPs | ||
Maintenance = The extent to which a program or policy becomes institutionalized or part of the routine organizational practices and policies | • Monitoring of patient inclusion | Hospital and pharmacies | |
• Inclusion of the IMAP into the routine activity over time | HCPs | ||
• Satisfaction (professionals and patients) | HCPs and patients | ||
Maintenance at the individual level = the long-term effects of a program on outcomes 6 months or more after the most recent intervention contact | • Adherence data | Pharmacies | |
• VL and CD4 counts | Hospital |